Analysts/Institutional Investor Meet/Con. Call Updates

Ref: NEPHROPLUS/SE/92 October 21, 2026 To To BSE Limited Na(cid:415)onal Stock Exchange of India Limited P.J. Towers, Dalal Street, 5th Floor, Exchange Plaza, Bandra (E), Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 544647 Scrip Symbol: NEPHROPLUS Through: BSE Lis(cid:415)ng Centre Through: NEAPS Sub: Intimation of schedule of Q2FY27 Earnings Call Ref: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Dear Sir/Madam, Pursuant to Regula(cid:415)on 30 read with Schedule III of the SEBI Lis(cid:415)ng Regula(cid:415)ons, as amended from (cid:415)me to (cid:415)me, we would like to inform you that the officials of the Company will be a(cid:425)ending a Results Conference Call to discuss on Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026 as per the details below: Day, Date & Time Type of Event Wednesday, November 4, 2026 at 11:00 A.M IST Q2FY27 Earnings Call Discussions will be based on publicly available informa(cid:415)on. No unpublished price sensi(cid:415)ve informa(cid:415)on (UPSI) is intended to be discussed during the interac(cid:415)ons. The above disclosure is available on the website of the Company www.nephroplus.com A copy of the invita(cid:415)on is a(cid:425)ached for your informa(cid:415)on. Yours sincerely, For Nephrocare Health Services Limited (Formerly Nephrocare Health Services Private Limited) Kishore Kathri Company Secretary & Head Legal ICSI M. No. F9895 Encl: a/a NephroPlus Earnings Conference Call Wednesday, 4th Nov 2026 11:00 am (IST) IIFL is pleased to invite you to join a conference call with the management of NephroPlus (NEPHROPL IN) to discuss the company’s business strategy and outlook post the declaration of its Q2FY27 financial results. Mr. Vikram Vuppala – Chairman & Managing Director Mr. Kamal Shah – Co-Founder Management participants Mr. Rohit Singh – Group CEO Mr. Prashant Goenka – Group Chief Financial Officer 4th Nov 2026 (Wednesday) – 11:00 am IST Date / Time (HK/Singapore – 1:30 pm, UK – 5:30 am, USA – 12:30 am ET) Conference dial-in numbers Pre-registration link Diamond Pass Registration India Primary Number +91 22 6280 1259 / +91 22 7115 8160 International Toll-free number USA 1-866 746 2133 UK 0-808 101 1573 Singapore 800-101 2045 Hong Kong 800-964 448 For further information, please contact: Naman Bagrecha | Tel: +91 22 4646 4718 | Email: naman.bagrecha@iiflcap.com Rahul Jeewani | Tel: +91 22 4646 4673 | Email: rahul.jeewani@iiflcap.com Aman Goyal | Tel: +91 22 4646 4705 | Email: aman.goyal@iiflcap.com Vighnesh Indure | Tel: +91 22 4646 4661 | Email: vighnesh.indure@iiflcap.com IIFL Capital Services Limited - 24th floor, One Lodha Place, Senapati Bapat Marg, Lower Parel (W), Mumbai 400 013, Tel: (91-22) 4646 4600, Fax: (91-22) 4646 4700